Use cautionMedical device recall · FDA · Published November 14, 2018
In2bones NeoSpan Compression Staple Recall: Wrong Drill Bit Size Hazard
In2bones recalls NeoSpan SuperElastic Compression Staple kits with wrong 3mm drill bit (should be 2mm). Affected lots: 9G88C0. Stop using immediately to avoid injury.
The NeoSpan Compression Staple (10x10x10) kits from two lots contain the wrong size drill bit. They contain a 3mm drill bit instead of a 2mm drill bit.
“In2bones NeoSpan Compression Staple Recall: Wrong Drill Bit Size Hazard.” GovInfoNow, updated August 20, 2026. https://govinfonow.com/recall/69474-in2bones-neospan-compression-staple-recall-wrong-drill-bit-size-hazard. Based on FDA recall #Z-0670-2019 (https://api.fda.gov/device/enforcement.json?search=recall_number:%22Z-0670-2019%22&limit=1).
In2bones USA, LLC voluntarily recalled NeoSpan SuperElastic Compression Staple w/Instruments kits because they contain the wrong size drill bit, according to the FDA. The Food and Drug Administration announced the recall on November 14, 2018.
The NeoSpan Compression Staple (10x10x10) kits from lot 9G88C0 contain a 3mm drill bit instead of the required 2mm drill bit, according to the FDA.
Context
GovInfoNow's records show In2bones USA, LLC has 3 other recalls on record since July 16, 2018. Other recent recalls of similar products include Synthes 2.4V TAP CORTEX SCREW Recall (February 25, 2026), Orthalign Drill Plate Recall: Bone Cut Risk from Manufacturing Defect (February 10, 2026) and Orthalign Drill Plate Recall: Risk of Bone Cut in Normal Use (February 10, 2026).
How to tell if you have this one
Check for the lot number 9G88C0 on the NeoSpan SuperElastic Compression Staple kit (Size 10x10x10, Part Number T50 SN010). The kit contains a 3mm drill bit instead of the required 2mm drill bit.
Brand
In2bones
Category
Medical device
Based on the official FDA remedy
What to do — step by step
Stop Using Immediately
Discontinue use of the recalled NeoSpan SuperElastic Compression Staple kits with lot number 9G88C0 to prevent potential injury.
Where it went and when
Where it was distributed
Distributed in 11 states.
Listed by the agency
Not listed
FDA distribution: “TX, VA, PA, MO, NJ, FL, TN, NC, OH, WI, LA” States read from FDA’s own wording; “not listed” means the notice does not name it.
States: Florida, Louisiana, Missouri, New Jersey, North Carolina, Ohio, Pennsylvania, Tennessee, Texas, Virginia, Wisconsin.
Recall timeline
FDA terminated this recall 6 months after the firm started it.
1Firm started the recall
2FDA classified it Class II
3Published in FDA’s Enforcement Report
4FDA terminated the recall
Dates from the agency record only; steps without a date are left out.
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
Official source: FDA Recall #Z-0670-2019 (November 14, 2018) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for Z-0670-2019 to see it in context.
Plain-language summary written by qwen3:4b on August 20, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.